Evid Invest
Holders — by stockHoldings — by fund

Deep Track Capital, LP

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001856083

$6.14B

disclosed book value

73

positions

8.2%

largest position share

Positions, as of 2026-09-30

top 74 of 73 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1GHGUARDANT HEALTH INC2.8M$500.4M8.2%
2BMRNBIOMARIN PHARMACEUTICAL INC6.4M$382.5M6.2%
3IMVTIMMUNOVANT INC9.2M$309.5M5%
4TARSTARSUS PHARMACEUTICALS INC3.8M$299.3M4.9%
5MANEVERADERMICS INC1.9M$230.3M3.8%
6VERAVERA THERAPEUTICS INC7.0M$226.0M3.7%
7PCVXVAXCYTE INC3.5M$199.9M3.3%
8ALKSALKERMES PLC4.5M$182.3M3%
9OCULOCULAR THERAPEUTIX INC21.9M$168.3M2.7%
10UTHRUNITED THERAPEUTICS CORP DEL300,040$162.6M2.6%
11GPCRSTRUCTURE THERAPEUTICS INC5.0M$156.3M2.5%
12GRALGRAIL INC1.1M$154.7M2.5%
13INSMINSMED INC1.4M$154.1M2.5%
14CMPSCOMPASS PATHWAYS PLC12.2M$151.3M2.5%
15GMABGENMAB A/S4.2M$149.2M2.4%
16AXSMAXSOME THERAPEUTICS INC.800,000$147.5M2.4%
17NRIXNURIX THERAPEUTICS INC6.0M$142.3M2.3%
18LBRXLB PHARMACEUTICALS INC3.4M$128.7M2.1%
19TNGXTANGO THERAPEUTICS INC4.5M$112.3M1.8%
20MAZEMAZE THERAPEUTICS INC4.1M$111.0M1.8%
21COAGHEMAB THERAPEUTICS HLDGS INC3.6M$110.6M1.8%
22GMABGENMAB A/SCALL2.8M$98.5M1.6%
23MLTXMOONLAKE IMMUNOTHERAPEUTICS8.1M$94.8M1.5%
24ORKAORUKA THERAPEUTICS INC1.1M$89.1M1.5%
25WGSGENEDX HOLDINGS CORP1.2M$86.8M1.4%
26TEMTEMPUS AI INCCALL1.0M$81.9M1.3%
27COGTCOGENT BIOSCIENCES INC2.5M$80.0M1.3%
28GHRSGH RESEARCH PLC3.3M$78.3M1.3%
29BCAXBICARA THERAPEUTICS INC4.1M$76.3M1.2%
30LTGOLATIGO BIOTHERAPEUTICS INC4.4M$73.6M1.2%
31CLDXCELLDEX THERAPEUTICS INC NEW2.1M$68.9M1.1%
32BBIOBRIDGEBIO PHARMA INC885,882$58.3M0.9%
33AVTXAVALO THERAPEUTICS INC3.6M$55.3M0.9%
34ALMSALUMIS INC7.5M$55.2M0.9%
35ALTALTIMMUNE INC19.3M$55.1M0.9%
36ATTOATTOVIA THERAPEUTICS INC3.2M$55.0M0.9%
37BLLNBILLIONTOONE INC500,000$53.2M0.9%
38ACRSACLARIS THERAPEUTICS INC9.3M$49.2M0.8%
39CRMDCORMEDIX INC6.3M$48.3M0.8%
40EWTXEDGEWISE THERAPEUTICS INC1.1M$46.6M0.8%
41VSTMVERASTEM INC5.7M$46.2M0.8%
42DFTXDEFINIUM THERAPEUTICS INC1.0M$38.1M0.6%
43GENBGENERATE BIOMEDICINES INC2.5M$37.7M0.6%
44MBXMBX BIOSCIENCES INC640,000$37.5M0.6%
45ANIPANI PHARMACEUTICALS INC500,000$36.3M0.6%
46VRDNVIRIDIAN THERAPEUTICS INC1.7M$35.2M0.6%
47HROWHARROW INC1.1M$32.9M0.5%
48OBXOBSIDIAN THERAPEUTICS INC2.1M$29.1M0.5%
49CRVSCORVUS PHARMACEUTICALS INC2.5M$28.7M0.5%
50NBIXNEUROCRINE BIOSCIENCES INC200,000$28.4M0.5%
51SLDBSOLID BIOSCIENCES INC3.6M$25.8M0.4%
52STTKSHATTUCK LABS INC3.7M$25.3M0.4%
53BEAMBEAM THERAPEUTICS INC1.0M$24.4M0.4%
54MNKDMANNKIND CORP5.0M$19.6M0.3%
55XENEXENON PHARMACEUTICALS INC500,000$18.6M0.3%
56OLMAOLEMA PHARMACEUTICALS INC2.1M$18.2M0.3%
57NKTRNEKTAR THERAPEUTICS300,000$18.2M0.3%
58DSGNDESIGN THERAPEUTICS INC1.3M$16.6M0.3%
59IPSCCENTURY THERAPEUTICS INC9.5M$16.2M0.3%
60DYNDYNE THERAPEUTICS INCCALL1.0M$16.1M0.3%
61XNCRXENCOR INC540,000$13.5M0.2%
62MPLTMAPLIGHT THERAPEUTICS INC1.3M$13.4M0.2%
63ENTAENANTA PHARMACEUTICALS INC1.0M$13.2M0.2%
64XFORX4 PHARMACEUTICALS INC4.5M$13.1M0.2%
65KARDKARDIGAN INC600,000$8.8M0.1%
66PMNPROMIS NEUROSCIENCES INC740,117$8.0M0.1%
67ENTXENTERA BIO LTD2.5M$7.1M0.1%
68RXSTRXSIGHT INC1.2M$6.0M0.1%
69RNAQURAINIER ACQUISITION CORP500,000$5.1M0.1%
70JTTTJATT III ACQUISITION CORP450,000$5.0M0.1%
71RACDRESEARCH ALLIANCE CORP IV400,000$4.6M0.1%
72TCGXTCGX ACQUISITION CORP300,000$3.8M0.1%
73ALGSALIGOS THERAPEUTICS INC444,110$2.5M0%
74CNTXCONTEXT THERAPEUTICS INC7.4M$2.2M0%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.